PFCs 17-point weekly tracking system captures the full scope of progress
N Engl J Med 2025;393:1796-1806 [9] Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial, December 2025: Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company [10] Fourth High-level Meeting of the UN General Assembly on the prevention and control of NCDs and the promotion of mental health and wellbeing (HLM4), September 2025: [11] Thousands of patients from Scotlands poorest areas to benefit from landmark UK government-funded obesity study, November 2025: Thousands of patients from Scotlands poorest areas to benefit from landmark UK government-funded obesity study - GOV.UK [12] Non-Traditional Channels: The Compounded GLP-1 Market
Week 2, left abdomen
If the cost, manual food logging, and accessibility requirements are acceptable to you, Noom may be worth a try
The incidence of acute pancreatitis with GLP-1 receptor agonist therapy in individuals with a known history of pancreatitis
However, in females, SD-fed rats had higher inflammation than WD-fed rats (F( 1,11 ) = 3.705, R 2 = 0.252, p = 0.007), this was primarily driven by high levels of TH2-produced, or anti-inflammatory, cytokines (F( 1,11 ) = 8.701, R 2 = 0.442, p = 0.002)